U.S. FDA Approves VRAYLAR® (cariprazine) as an Adjunctive Treatment for Major Depressive Disorder
19/12/2022
Business related Regulatory Central Nervous System API - CARIPRAZINE PARTNER - ALLERGAN / ABBVIE / ACTAVIS PRODUCT - VRAYLAR
2049 kb 19/12/2022 pdf